Clinical Trials · NCT03059719
Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- PegBio Co., Ltd.
- Enrollment
- 36
- Start date
- Apr 2015
- Locations
- 1 site, China
- Primary endpoint
- Incidence of treatment-emergent AE (safety and tolerability)